コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 posi's sarcoma-associated herpesvirus (KSHV; human herpesvirus 8).
2 with Kaposi sarcoma-associated herpesvirus (human herpesvirus 8).
3 aposi's sarcoma-associated herpesvirus (KSHV/human herpesvirus 8).
4 -associated herpes virus (KSHV), also called human herpesvirus 8.
5 es an IRES recently found on mRNA encoded by human herpesvirus 8.
6 arcoma-associated herpesvirus, also known as human herpesvirus 8.
7 known as KS-associated herpesvirus (KSHV) or human herpesvirus 8.
8 (KS) herpesvirus (KSHV), also referred to as human herpesvirus 8.
9 ted to rhesus macaque rhadinovirus (RRV) and human herpesvirus 8.
10 e of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.
11 herpesviruses such as Epstein-Barr virus and human herpesvirus 8.
12 re 'pirated' by Kaposi's sarcoma herpesvirus/human herpesvirus-8.
13 d to Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
14 in human cells by the Kaposi sarcoma-related human herpesvirus-8.
15 iation, sex hormones, and the KS herpesvirus/human herpesvirus-8.
16 liferative disorder caused by infection with human herpesvirus-8.
17 esvirus family including cytomegalovirus and human herpesvirus-8.
18 n shown to be associated with infection with human herpesvirus-8.
19 ction by Kaposi's sarcoma herpesvirus (KSHV)/human herpesvirus-8.
20 's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, a necessary, albeit not sufficient,
21 posi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8, a virus that appears to be involved
22 osi's sarcoma- associated herpesvirus (KSHV)/human herpesvirus 8, a virus that may be involved in the
24 cribed the properties of a cyclin encoded by human herpesvirus 8 (also known as Kaposi's sarcoma-asso
27 rcoma tumor cells are latently infected with human herpesvirus-8 and hence resistant to antiherpesvir
28 he Betaherpesvirinae) and ORF10 and ORF11 in human herpesvirus 8 (and counterparts in other members o
30 of KS is KS herpesvirus (KSHV; also known as human herpesvirus-8), and viral proteins can induce KS-a
31 rus, Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8, and human T-cell lymphotrophic viru
32 erpesviruses, including herpesvirus saimiri, human herpesvirus 8, and MHV68, encode proteins with ext
34 ma-associated herpesvirus (KSHV; also called human herpesvirus 8) belong to the gamma-2 grouping of h
35 osi's sarcoma-associated herpesvirus (KSHV) (human herpesvirus 8) binds to adherent target cell surfa
36 ssociated herpesvirus (KSHV, also designated human herpesvirus 8) can establish a latent infection in
37 s induced by KS-associated herpesvirus (KSHV/human herpesvirus 8) cause substantial morbidity and mor
39 a-associated herpesvirus, also identified as human herpesvirus 8, contains genes producing proteins t
40 This review discusses mechanisms by which human herpesvirus-8 contributes to tumorigenesis and how
41 posi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8, disrupts latency and drives lytic r
46 osi sarcoma-associated herpesvirus (KSHV; or human herpesvirus-8)-encoded protein called K-bZIP (also
49 in HHV-8 latent and lytic biology.IMPORTANCE Human herpesvirus 8-encoded IRF homologues were the firs
51 posi's sarcoma-associated herpesvirus (KSHV; human herpesvirus 8) encodes a chemokine-like G protein-
52 vely, the replication and maintenance of the human herpesvirus-8 episome during latency can be disrup
53 -associated herpesvirus (KSHV; also known as human herpesvirus-8) establishes latent and lytic infect
54 's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, from latency requires transcription
55 s sarcoma (KS)-associated herpesvirus (KSHV)/human herpesvirus 8 functions as the key regulator to in
56 Kaposi's sarcoma (KS)-associated herpesvirus/human herpesvirus 8 gene encoding a G protein-coupled re
57 the Kaposi's sarcoma-associated herpesvirus [human herpesvirus 8] gene encoding latency-associated nu
58 posi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 genes in a cultured primary effusion
60 i's sarcoma-associated herpesvirus (KSHV) or human herpesvirus 8 has been established as the etiologi
61 associated herpesvirus (KSHV) (also known as human herpesvirus 8) has been implicated in the pathogen
62 ma-associated herpesvirus (KSHV, also called human herpesvirus 8) has been linked to KS and primary e
63 ma-associated herpesvirus (KSHV; also called human herpesvirus 8) has properties of a ligand-independ
64 's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, has been implicated in the developm
65 mely Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8, has been confirmed to be a direct c
66 nflammatory protein-II (vMIP-II), encoded by human herpesvirus-8, has garnered interest because of it
67 (cytomegalovirus, herpes simplex virus-1/2, human herpesvirus 8, hepatitis E virus, parvovirus B19).
69 ypothesized that they could be infected with human herpesvirus 8 (HHV-8) (Kaposi's sarcoma [KS]-assoc
73 posi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) and causes KSHV-like disease
74 o investigate a possible association between human herpesvirus 8 (HHV-8) and prostate cancer, we eval
75 greement between assays for the detection of human herpesvirus 8 (HHV-8) antibodies has been limited.
78 oma (cKS) is an inflammatory tumor caused by human herpesvirus 8 (HHV-8) commonly observed in elderly
81 posi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) displays two distinct life s
82 osi's sarcoma (KS)-associated herpesvirus or human herpesvirus 8 (HHV-8) DNA and transcripts have bee
83 based system) was developed for detection of human herpesvirus 8 (HHV-8) DNA in clinical specimens.
86 posi's sarcoma associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) encodes an immediate early t
94 e cytotoxic T lymphocyte (CTL) response to 5 human herpesvirus 8 (HHV-8) homologues of lytic proteins
95 Kaposi sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) in sub-Saharan Africa sugges
96 children, but there is a paucity of data on human herpesvirus 8 (HHV-8) incidence and routes of infe
97 lymphoproliferative disorder associated with human herpesvirus 8 (HHV-8) infection among persons with
106 plantation through reactivation of recipient human herpesvirus 8 (HHV-8) infection or through donor-d
123 rotein coupled receptor (vGPCR) specified by human herpesvirus 8 (HHV-8) open reading frame 74 (ORF74
137 e association between injection drug use and human herpesvirus 8 (HHV-8) was examined to investigate
138 -1, HSV-2), varicella-zoster virus (VZV) and human herpesvirus 8 (HHV-8) were not or rarely detected
141 virus and is the rhesus macaque homologue of human herpesvirus 8 (HHV-8), also known as Kaposi's sarc
142 novirus (RRV), the rhesus macaque homolog of human herpesvirus 8 (HHV-8), also known as Kaposi's sarc
144 epithelial cells persistently infected with human herpesvirus 8 (HHV-8), an oncogenic herpesvirus th
145 infected patients, Epstein-Barr virus (EBV), human herpesvirus 8 (HHV-8), cytomegalovirus (CMV), and
146 Other viruses, such as hepatitis B virus or human herpesvirus 8 (HHV-8), establish persistent infect
147 associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is a cancer-related human v
149 a-associated herpesvirus (KSHV), also called human herpesvirus 8 (HHV-8), is the likely etiological a
153 0-CD200R pathway during infection, including human herpesvirus 8 (HHV-8), the causative agent of Kapo
155 Little is known about cellular immunity to human herpesvirus 8 (HHV-8), the virus associated with K
156 erent efficiencies and with the exception of human herpesvirus 8 (HHV-8), these chimeric variants res
157 t be the result of widespread infection with human herpesvirus 8 (HHV-8), we determined the prevalenc
160 l interleukin-6 (vIL-6) homologue in various human herpesvirus 8 (HHV-8)-associated diseases, in situ
161 evious analyses of vIL-6 activity.IMPORTANCE Human herpesvirus 8 (HHV-8)-encoded viral interleukin-6
170 aque (RM) monkeys that is closely related to human herpesvirus 8 (HHV-8)/Kaposi's Sarcoma-associated
171 's sarcoma-associated herpesvirus (KSHV) [or human herpesvirus 8 (HHV-8)] is the most frequent cause
182 onsequence of dysregulated expression of the human herpesvirus-8 (HHV-8 or KSHV)-encoded G protein-co
183 effusion lymphomas (PEL) are associated with human herpesvirus-8 (HHV-8) and usually occur in immunoc
185 ranean Basin, despite the high prevalence of human herpesvirus-8 (HHV-8) infection in this region.
186 roduction and immune regulation coupled with human herpesvirus-8 (HHV-8) infection underlie the curre
187 Kaposi sarcoma-associated herpesvirus (KSHV)/human herpesvirus-8 (HHV-8) is causally associated with
188 the past few years, it has become clear that human herpesvirus-8 (HHV-8) is critical to the developme
189 lymphoma (PEL) is a B-cell lymphoma in which human herpesvirus-8 (HHV-8) is found within all tumor ce
196 nvestigated nucleotide-sequence variation in human herpesvirus-8 (HHV-8) subgenomic DNA, amplified fr
197 uses, including Epstein-Barr virus (EBV) and human herpesvirus-8 (HHV-8), also known as Kaposi's sarc
198 s led to a dramatic rise in the incidence of human herpesvirus-8 (HHV-8)-associated Kaposi's sarcoma
199 S), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KS
201 osi's sarcoma-associated herpesvirus (KSHV) (human herpesvirus 8 [HHV-8]) induces the host cell's pre
202 aposi's sarcoma-associated herpesvirus (KSHV/human herpesvirus 8 [HHV-8]) is a gamma-2-herpesvirus re
203 -associated herpesvirus (KSHV; also known as human herpesvirus 8 [HHV-8]) is a herpesvirus linked to
204 -associated herpesvirus (KSHV; also known as human herpesvirus 8 [HHV-8]) is the etiologic agent of K
205 sarcoma-associated herpesvirus (also called human herpesvirus 8 [HHV-8]) replication and transcripti
206 -associated herpesvirus (KSHV; also known as human herpesvirus 8 [HHV-8]), Epstein-Barr virus (EBV),
207 ma-associated herpesvirus (KSHV; also called human herpesvirus 8 [HHV-8]), upon being reactivated, ca
208 i's sarcoma-associated herpesvirus (KSHV, or human herpesvirus-8 [HHV-8]) has another, alternative em
209 posi's sarcoma-associated herpesvirus (KSHV; human herpesvirus-8 [HHV-8]) with agents such as 12-O-te
210 nfection with potentially oncogenic viruses (human herpesvirus-8 [HHV-8], Epstein-Barr virus), and ac
211 posi's sarcoma-associated herpesvirus (KSHV [human herpesvirus 8; HHV-8]) open reading frame 57 (ORF5
212 y and epidemiologic studies have established human herpesvirus 8 (HHV8) as an etiologic agent of Kapo
214 osi's sarcoma (KS)-associated herpesvirus or human herpesvirus 8 (HHV8) DNA is found consistently in
217 o determine the prevalence and correlates of human herpesvirus 8 (HHV8) in saliva, mouth, cervical, v
218 central Italy and a surveillance program for human herpesvirus 8 (HHV8) infection after transplant, a
220 arcoma (KS)-associated herpesvirus (KSHV) or human herpesvirus 8 (HHV8) is common in certain parts of
221 say to identify two functional copies of the human herpesvirus 8 (HHV8) lytic origin of DNA replicati
223 Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (HHV8) ORF50 encodes a transactivato
228 The lytic origins of DNA replication for human herpesvirus 8 (HHV8), oriLyt-L and oriLyt-R, are l
230 nsfection replication assay identified eight human herpesvirus 8 (HHV8)-encoded proteins required for
231 n 17577) genome is essentially colinear with human herpesvirus 8 (HHV8)/Kaposi's sarcoma-associated h
233 utively active chemokine receptor encoded by human herpesvirus 8 (HHV8, also known as Kaposi sarcoma
236 aposi's sarcoma-associated herpesvirus (KSHV/human herpesvirus 8 [HHV8]) and Epstein-Barr virus (EBV/
237 i's sarcoma-associated herpesvirus (KSHV; or human herpesvirus 8 [HHV8]) is implicated in the pathoge
238 ma-associated herpesvirus (KSHV; also called human herpesvirus 8 [HHV8]), the switch from latency to
239 rize major recent findings on the biology of human herpesvirus-8, i.e. Kaposi's sarcoma-associated he
240 In contrast, many of the cells infected with human herpesvirus-8 in multicentric Castleman's disease
243 3) new information regarding transmission of human herpesvirus 8 infection; 4) new information regard
244 eries regarding Kaposi's sarcoma herpesvirus/human herpesvirus-8 infection and its activation of sign
245 i's sarcoma-associated herpesvirus (KSHV, or human herpesvirus 8) infection in individuals remains a
246 Kaposi's sarcoma-associated herpesvirus (or human herpesvirus-8) infection, present as malignant lym
249 6 homologue (viral interleukin-6 [vIL-6]) of human herpesvirus 8 is implicated in viral pathogenesis
251 Viral interleukin-6 (vIL-6) specified by human herpesvirus 8 is, unlike its cellular counterpart,
253 associated herpesvirus (KSHV) (also known as human herpesvirus 8) is a gamma-2 herpesvirus believed t
254 s sarcoma-associated herpesvirus (also named human herpesvirus 8) is a gamma-herpesvirus that undergo
255 persistent gamma-herpesvirus infection (EBV, human herpesvirus 8) is a significant problem in AIDS pa
256 posi's sarcoma-associated herpesvirus (KSHV; human herpesvirus 8) is an oncogenic gammaherpesvirus th
257 S)-associated herpesvirus (KSHV; also called human herpesvirus 8) is believed to be the etiologic age
258 i's sarcoma-associated herpesvirus (KSHV, or human herpesvirus 8) is etiologically linked to KS, and
259 ma-associated herpesvirus (KSHV, also called human herpesvirus 8) is linked to the development of Kap
260 oma-associated herpesvirus (KSHV; also named human herpesvirus 8) is necessary but not sufficient for
261 posi's sarcoma-associated herpesvirus (KSHV, human herpesvirus 8) is the causative agent of Kaposi's
262 -associated herpesvirus (KSHV; also known as human herpesvirus 8) is the etiologic agent of Kaposi's
263 si's sarcoma-associated herpesvirus (KSHV or human herpesvirus-8) is frequently tumorigenic in immuno
264 associated herpesvirus (KSHV), also known as human herpesvirus 8, is an etiologic agent of KS, primar
265 's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, is associated with three proliferat
266 associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent of Kaposi sa
267 associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent underlying K
268 -related herpesvirus (KSHV), also designated human herpesvirus 8, is the presumed etiologic agent of
269 be novel attributes of the cyclin encoded by Human Herpesvirus 8 (K cyclin) that enable it to subvert
270 The rhadinovirus 1 (RV1) lineage consists of human herpesvirus 8, Kaposi's sarcoma-associated herpesv
272 an gammaherpesviruses Epstein-Barr virus and human herpesvirus 8/Kaposi's sarcoma-associated herpesvi
273 gammaherpesviruses, Epstein-Barr virus, and human herpesvirus 8/Kaposi's sarcoma-associated herpesvi
274 for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) gene expression bears r
275 Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) interacts with cell sur
277 iate Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) reactivation from laten
278 Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) RTA is an important pro
280 irus Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV8), exploit microtubule (MT
281 osi's sarcoma-associated herpesvirus (KSHV) (human herpesvirus 8), latent genes have been implicated
282 associated herpesvirus (KSHV) (also known as human herpesvirus 8) latently infects KS tumors, primary
284 osi's sarcoma-associated herpesvirus (KSHV)/(human herpesvirus 8), plays a critical role in balancing
285 Epstein-Barr virus-infected lymphocytes, and human herpesvirus 8-positive primary effusion lymphoma,
287 tor TNF-alpha, the HIV-1 Tat protein, or the human herpesvirus 8 protein ORF74, was inhibited by rito
291 t findings show Kaposi's sarcoma herpesvirus/human herpesvirus-8 specific signaling pathways and pira
292 ma is driven by Kaposi's sarcoma herpesvirus/human herpesvirus-8-specific pathways, which include vir
293 Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, the most recently discovered human
294 erpesvirus drugs can be overcome by inducing human herpesvirus-8 to reenter the lytic cascade in the
295 s (CMV), herpes simplex virus types 1 and 2, human herpesvirus 8) using multiplex serology on blood s
296 CMV, herpes simplex virus types 1 and 2, and human herpesvirus 8 was 99.4%, 74.9%, 26.2%, 8.0%, and 1
299 on with HIV and Kaposi's sarcoma herpesvirus/human herpesvirus-8, which leads to the development of a
300 -associated herpesvirus (KSHV, also known as human herpesvirus 8) with the development of the disease